SecBot SecBot
424B5 ·Filed Jul 24, 2026

AIMD

Ainos, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001493152-26-034510
Notable filing: 424B5
Actionable Insight ▼ Bearish

The ATM increase signals persistent cash burn at a micro-cap with a $13M market cap. Monitor for actual share sales via daily volume and subsequent 424B5 filings; each tranche sold will pressure the stock.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
AIMD ▼ -33.46% at T+60d
SHORT call ✓ call won +33.46% · α vs SPY +36.76% · entry $1.40 → $0.9315
Entry = T+0 close
Jul 24, 2026
via day close
T+1d
-5.00%
call +5.00% · α +5.02%
$1.33
settled 3mo ago
T+5d
-2.86%
call +2.86% · α +3.23%
$1.36
settled 3mo ago
T+20d
+2.14%
call -2.14% · α +1.48%
$1.43
settled 2mo ago
T+60d
-33.46%
call +33.46% · α +36.76%
$0.9315
settled 8d ago

Price Chart

Loading chart...

Executive Summary

Ainos, Inc. filed a 424B5 prospectus supplement to increase its at-the-market (ATM) offering capacity by up to $1.35 million via H.C. Wainwright. The company has already sold $2.71 million under the existing sales agreement and $1.96 million under the shelf's I.B.6 limit in the prior 12 months. This filing signals ongoing capital needs and potential dilution for a micro-cap with a $13M market cap.

Key Facts

  • Ainos is increasing its ATM offering by up to $1,346,165 of common stock through H.C. Wainwright.
  • The company has already sold $2,714,728.20 under the existing Sales Agreement.
  • Public float is approximately $9.92 million, based on 8.54M shares outstanding and a $3.16 reference price.
  • Affiliates hold 5.4M of the 8.5M outstanding shares, indicating a tightly held float.
  • The offering is limited to one-third of public float per 12-month period under General Instruction I.B.6 of Form S-3.

Financial Impact

Potential dilution of up to ~13.6% of the current public float ($1.35M / $9.92M), adding to $2.71M already sold under the same ATM program.

dilutionshare countpublic float

Risk Factors

  • Further dilution as the company draws down the new ATM capacity.
  • Low public float (~$9.9M) means even modest ATM sales can materially impact the stock price.
  • No disclosed use of proceeds or operating update — suggests ongoing cash needs without a clear catalyst.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001493152-26-034510
Document: 0001493152-26-034510-index-headers.html0001493152-26-034510
Document: 0001493152-26-034510-index.html0001493152-26-034510
Document: 0001493152-26-034510.txt0001493152-26-034510
5 reports for AIMD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AIMD — sortable, filterable
TypeNow
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$0.9315awaiting T+20—$0.7830 (−15.94%)
Sep 28, 2026
28d ago
8-K
BULLISH ★ 5/10
$1.33 $0.7825▼ −41.17%▼ −41.13%$0.7830 (−41.13%)
Jul 24, 2026
13w ago
424B5
BEARISH ★ 6/10
$1.40 $1.43▼ −2.14%▲ +1.48%$0.7830 (+44.07%)
Jul 9, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$1.89 $1.49▼ −21.16%▼ −23.59%$0.7830 (−58.57%)
May 27, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$2.74 $1.73▼ −36.86%▼ −33.72%$0.7830 (−71.42%)
Showing 5 of 5

US Market Status

Market Closed — Opens Wed (10h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 24, 2026